346 related articles for article (PubMed ID: 32473644)
1. Safety and efficacy of direct Cardiac Shockwave Therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial.
Pölzl L; Nägele F; Graber M; Hirsch J; Lobenwein D; Mitrovic M; Mayr A; Theurl M; Schreinlechner M; Pamminger M; Dorfmüller C; Grimm M; Gollmann-Tepeköylü C; Holfeld J
Trials; 2020 May; 21(1):447. PubMed ID: 32473644
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial-an update.
Nägele F; Pölzl L; Graber M; Hirsch J; Mayr A; Pamminger M; Troger F; Theurl M; Schreinlechner M; Sappler N; Dorfmüller C; Mitrovic M; Ulmer H; Grimm M; Gollmann-Tepeköylü C; Holfeld J
Trials; 2022 Dec; 23(1):988. PubMed ID: 36494706
[TBL] [Abstract][Full Text] [Related]
3. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK
Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458
[TBL] [Abstract][Full Text] [Related]
4. Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
Holfeld J; Nägele F; Pölzl L; Engler C; Graber M; Hirsch J; Schmidt S; Mayr A; Troger F; Pamminger M; Theurl M; Schreinlechner M; Sappler N; Ruttmann-Ulmer E; Schaden W; Cooke JP; Ulmer H; Bauer A; Gollmann-Tepeköylü C; Grimm M
Eur Heart J; 2024 Jun; ():. PubMed ID: 38898573
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction.
Bista R; Zghouzi M; Jasti M; Lichaa H; Kerrigan J; Haddad E; Alraies MC; Paul TK
Curr Cardiol Rep; 2024 May; 26(5):435-442. PubMed ID: 38642298
[TBL] [Abstract][Full Text] [Related]
6. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.
Karantalis V; DiFede DL; Gerstenblith G; Pham S; Symes J; Zambrano JP; Fishman J; Pattany P; McNiece I; Conte J; Schulman S; Wu K; Shah A; Breton E; Davis-Sproul J; Schwarz R; Feigenbaum G; Mushtaq M; Suncion VY; Lardo AC; Borrello I; Mendizabal A; Karas TZ; Byrnes J; Lowery M; Heldman AW; Hare JM
Circ Res; 2014 Apr; 114(8):1302-10. PubMed ID: 24565698
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes of Cardiac Shockwave Therapy in Severe Coronary Artery Disease Patients after Coronary Artery Bypass Grafting.
Wang J; Jia N; Liu B; Zhang R; Liu B; Lan M; Liu J; Yao Z; He Q
Int Heart J; 2023 Mar; 64(2):137-144. PubMed ID: 36927932
[TBL] [Abstract][Full Text] [Related]
8. Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization.
Bonow RO; Castelvecchio S; Panza JA; Berman DS; Velazquez EJ; Michler RE; She L; Holly TA; Desvigne-Nickens P; Kosevic D; Rajda M; Chrzanowski L; Deja M; Lee KL; White H; Oh JK; Doenst T; Hill JA; Rouleau JL; Menicanti L;
JACC Cardiovasc Imaging; 2015 Oct; 8(10):1121-1129. PubMed ID: 26363840
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
10. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
[TBL] [Abstract][Full Text] [Related]
11. Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction.
Panza JA; Holly TA; Asch FM; She L; Pellikka PA; Velazquez EJ; Lee KL; Borges-Neto S; Farsky PS; Jones RH; Berman DS; Bonow RO
J Am Coll Cardiol; 2013 May; 61(18):1860-70. PubMed ID: 23500234
[TBL] [Abstract][Full Text] [Related]
12. Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial.
Mark DB; Knight JD; Velazquez EJ; Wasilewski J; Howlett JG; Smith PK; Spertus JA; Rajda M; Yadav R; Hamman BL; Malinowski M; Naik A; Rankin G; Harding TM; Drew LA; Desvigne-Nickens P; Anstrom KJ
Ann Intern Med; 2014 Sep; 161(6):392-9. PubMed ID: 25222386
[TBL] [Abstract][Full Text] [Related]
13. Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the PERFECT Phase III randomized multicenter trial: study protocol for a randomized controlled trial.
Donndorf P; Kaminski A; Tiedemann G; Kundt G; Steinhoff G
Trials; 2012 Jul; 13():99. PubMed ID: 22747980
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3.
Wolfien M; Klatt D; Salybekov AA; Ii M; Komatsu-Horii M; Gaebel R; Philippou-Massier J; Schrinner E; Akimaru H; Akimaru E; David R; Garbade J; Gummert J; Haverich A; Hennig H; Iwasaki H; Kaminski A; Kawamoto A; Klopsch C; Kowallick JT; Krebs S; Nesteruk J; Reichenspurner H; Ritter C; Stamm C; Tani-Yokoyama A; Blum H; Wolkenhauer O; Schambach A; Asahara T; Steinhoff G
EBioMedicine; 2020 Jul; 57():102862. PubMed ID: 32629392
[TBL] [Abstract][Full Text] [Related]
15. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.
Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Lima EG; Vieira RD; Garcia RM; Favarato D; Segre CA; Pereira AC; Soares PR; Ribeiro E; Lemos P; Perin MA; Strunz CC; Dallan LA; Jatene FB; Stolf NA; Hueb AC; Dias R; Gaiotto FA; da Costa LM; Oikawa FT; de Melo RM; Serrano CV; de Ávila LF; Villa AV; Filho JR; Nomura C; Ramires JA; Kalil Filho R;
BMC Cardiovasc Disord; 2012 Aug; 12():65. PubMed ID: 22898311
[TBL] [Abstract][Full Text] [Related]
16. STICH3C: Rationale and Study Protocol.
Fremes SE; Marquis-Gravel G; Gaudino MFL; Jolicoeur EM; Bédard S; Masterson Creber R; Ruel M; Vervoort D; Wijeysundera HC; Farkouh ME; Rouleau JL;
Circ Cardiovasc Interv; 2023 Aug; 16(8):e012527. PubMed ID: 37582169
[TBL] [Abstract][Full Text] [Related]
17. Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial.
Anastasiadis K; Antonitsis P; Westaby S; Reginald A; Sultan S; Doumas A; Efthimiadis G; Evans MJ
J Cardiovasc Transl Res; 2016 Jun; 9(3):202-213. PubMed ID: 27037806
[TBL] [Abstract][Full Text] [Related]
18. Does the extended use of arterial grafts compromise the myocardial recovery after coronary artery bypass grafting in left ventricular dysfunction?
Jegaden O; Bontemps L; de Gevigney G; Eker A; Montagna P; Chatel C; Itti R; Mikaeloff P
Eur J Cardiothorac Surg; 1998 Oct; 14(4):353-9. PubMed ID: 9845138
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of a prospective, randomised study of retrograde application of bone marrow aspirate concentrate (BMAC) through coronary sinus in patients with congestive heart failure of ischemic etiology (the RETRO study).
Pleva L; Kukla P; Vítková K; Procházka V
BMC Cardiovasc Disord; 2019 Jan; 19(1):32. PubMed ID: 30704414
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
